The Architecture of Failure: 19 Reasons New Zealand Companies Stall in the US Market

Treating the US as a single market

The US is not one market. It is 50 distinct state markets with different tax regimes, employment laws, professional licensing rules, regulatory bodies, and commercial conditions. A company that launches “in the US” without selecting a state has not made a market entry decision. It has deferred one.

New Zealand’s unitary regulatory system — one IRD, one employment law, one GST rate — creates a cognitive assumption that the US works the same way. It does not. California’s paid leave and termination requirements are categorically different from Texas’s at-will employment. A distribution agreement signed in one state needs legal review before it applies in another. A remote employee in Oregon can trigger state income tax nexus for the company’s entire US revenue.

The treatment: before a dollar is spent in the US, select a single state as the entry point based on customer concentration, regulatory environment, and talent access. Treat expansion into a second state as a deliberate, funded event. California, Texas, New York, and Illinois each warrant their own market plan.

Underestimating customer acquisition cost by 4–6x

In New Zealand, a challenger brand can gain traction by being better than one or two tired incumbents. In the US, every digital keyword, every trade show, and every minute of a buyer’s attention is priced in a global auction with venture-subsidized competitors on every side.

Xero’s international customer acquisition cost is 3x its ANZ rate, and that multiple has grown over 50% since the pandemic. Pushpay’s operating expenses ran at 93% of revenue in FY18 as it discovered what it actually cost to acquire US churches at scale. Zip Co spent US$196 per customer to acquire approximately 1 million US users while generating only US$54.93 in annual revenue per customer — a ratio that cannot be called a business model.

The treatment: model the US on a 4–6x CAC multiplier before entry. If the pricing and margin structure cannot sustain an 18–24 month CAC payback period, the business model must be redesigned for US conditions before the campaign budget is approved.

Undercapitalising entry by 3–5x

NZ founders budget for US entry based on NZ cost structures. US legal and accounting services run 3–10x NZ rates. A senior sales hire in San Francisco or New York costs 2–3x the NZ equivalent. Marketing in a competitive US category runs 3–5x. The cost of a single FDA registration for a life sciences company can reach US$4 million before one unit is sold.

EROAD’s US retreat was accompanied by a NZ$135 million goodwill impairment. Orion Health was down to $6 million in cash by March 2017 after $51.5 million in net outflows — three years after its IPO. The company survived only because its founder Ian McCrae put his own money into an emergency rights issue.

The treatment: build a US entry budget that multiplies NZ operating costs by 2.5–3x for the first 24 months, adds explicit line items for legal entity setup, multi-state tax registration, and compliance, and funds the first 12 months under a “no revenue” assumption. Commit capital before the first US employee is hired, not after.

Confusing total addressable market with accessible market

The US TAM looks enormous. NZ founders see the size and respond by going wide — national campaigns, multiple verticals, every segment. The result is micro-presence: everywhere in general, nowhere in particular. US buyers reward vertical depth and specific expertise.

Pushpay set out to capture 50% of medium-to-large US churches. Customer growth ran at 79% in FY17 — then collapsed to 8% the following year, and 5% the year after that. Not because the market was saturated, but because the easy-to-reach customers had been reached and the rest required a fundamentally different sales motion that the company had not designed.

The treatment: identify a single beachhead — one primary use case, one buyer role, one industry vertical, one constrained geography — and prove the model there before expanding. The first year in the US is a validation exercise, not a revenue plan.

Getting the first US hire wrong

The first US-based employee is the highest-leverage decision in any US entry. This person must operate autonomously, translate between NZ product culture and US market reality, generate customer feedback that can actually improve the product, and build commercial relationships without constant founder support. The person who can do all of those things simultaneously is rare and expensive.

The most common mistake is hiring an expensive US executive — VP Sales, $220–250k OTE — who was built for a company that already has a working pipeline, a known brand, and a support team. They fail not because they are bad at their job but because the job they are being asked to do is not the one they were trained for. The cycle repeats. The company loses 12–18 months and $200–400k.

The treatment: send a trusted NZ team member with product knowledge and commercial instincts as the first US presence. Design the role before filling it. The first hire is a builder, not a scaler. The playbook must exist in writing before the hire begins — not in the founder’s head.

Applying NZ pricing logic to a US market

NZ pricing is typically cost-plus or a competitive spread against one or two domestic incumbents. The US has incumbents using zero-margin software layers to capture high-value transaction or payment spreads — and NZ companies arrive with flat-rate or subscription models that look expensive by comparison, without understanding why.

Vend's subscription-based POS competed against Square's free-tier model, which monetised through payments. The pricing architecture was not wrong for New Zealand. It was structurally non-competitive in a market where the dominant player had removed the software cost from the equation entirely.

The problem is not always that NZ companies price too high. They also price too low. In US B2B, price is a quality signal. If your product replaces a $200,000-per-year headcount, pricing it at $5,000 per year does not look competitive. It looks like the product does not work.

The treatment: design a pricing architecture specifically for the US before entry. Benchmark against US competitors, not NZ ones. Decide what business model — subscription, usage-based, transaction spread, value-share — can both compete with US incumbents and sustain US-level CAC.

Running a generalist sales team in a specialist market

In New Zealand, one sales representative typically finds their own leads, runs the demo, closes the deal, and manages the account after signing. US B2B sales — particularly in SaaS — runs on a specialist pod: SDRs who qualify inbound, BDRs who prospect outbound, Account Executives who close, Customer Success who retain. These are different jobs. The skills do not transfer between them.

NZ companies hire a US Account Executive at $220–250k OTE and expect them to build their own pipeline. The AE spends 70% of their time cold-calling — work they are not trained for, at salary levels that cannot be justified by the output. They miss quota. The founder concludes the hire was bad. The hire was not bad. The system was wrong.

The treatment: design the sales pod before hiring the first person into it. Decide whether to use an outsourced SDR-as-a-service model to build pipeline before bringing an AE on board. The first US sales hire should be stepping into a system, not building one from scratch while carrying a number.

Underestimating state-level regulatory complexity

Getting the federal compliance layer right — an EIN, a Delaware C-Corp, an understanding of FTC and FDA requirements — creates a dangerous false confidence. It is the beginning of the compliance architecture, not the end of it.

State-level requirements are a separate and equally demanding surface. California's Prop 65 notification requirements apply to any product sold in California. California's Privacy Rights Act and New York's SHIELD Act create data handling obligations that do not exist in New Zealand. HIPAA applies to any company touching US healthcare data. FERPA applies to anyone in the education sector. Employment laws vary dramatically by state.

Rakon — one of NZ's most sophisticated technology exporters — lost a NZ$390 million acquisition by Nasdaq-listed Skyworks because its compliance architecture had not been designed for US regulatory scrutiny. A single customer relationship that appeared legitimate in NZ created an export controls liability that killed the deal.

The treatment: engage US legal and tax advisors to map the specific state-level obligations relevant to your business model before any US activity begins. Treat this as a structural design requirement, not an administrative task.

Building up invisible tax liabilities across state lines

New Zealand has one GST rate administered by one Inland Revenue Department. The US has 50 state tax regimes, thousands of local tax jurisdictions, and the South Dakota v. Wayfair Supreme Court ruling — which established that revenue thresholds alone, without any physical presence, can trigger sales tax collection obligations in a state.

A SaaS company that scales to $2 million in US revenue spread across 35 states may have triggered filing obligations in 15 of them without realising it. These liabilities do not surface during normal operations. They surface during Series B due diligence or acquisition — as a valuation holdback, or as a deal that doesn't close.

Fonterra, one of New Zealand's most sophisticated global exporters, lost its licence to directly import cheese into the US because a deadline was missed. A senior director publicly acknowledged it as “human error.” The US has zero tolerance for administrative errors. A missed deadline means lost market access, not an extension.

The treatment: implement automated compliance tools — Stripe Tax, Avalara, Anrok — from the first dollar of US revenue. Design a tiered state strategy that limits geographic footprint until the operational infrastructure to manage a wider tax surface exists.

Under-designing the channel and distribution architecture

NZ companies build direct sales capability because that is what built the business at home. The US often requires indirect distribution — resellers, integrators, value-added resellers, referral networks — that come with expectations NZ companies are not prepared for: 20–50% margin requirements, dedicated channel management, co-marketing investment, sales enablement programmes.

A company that signs a national distribution agreement and assumes the sales will follow has not designed a channel strategy. It has delegated a sales problem to a partner who has 50 other products to sell and no particular reason to prioritise this one.

Comvita's North American revenue dropped 37% in a single half-year period after losing distribution with one customer. When a single distribution relationship represents that proportion of revenue, the channel architecture has not been designed. It has been assembled.

The treatment: design the channel architecture before hiring channel staff. Build the pricing to include channel margin. Hire a dedicated channel manager as one of the first three US hires, not as an afterthought once revenue has stalled.

Scaling founder heroics instead of building systems

The founder flies to the US for key meetings. Works US hours from Auckland. Closes the first deals personally. This is how every market entry begins, and it is appropriate for validating the model. It is not a scalable business.

Chris Heaslip of Pushpay said it plainly on his departure from the company he co-founded: “In the early days, it's about sheer persistence. From $100m to $300m, it's about people, processes and systems.” Pushpay stalled at approximately US$181 million in revenue despite US$237.5 million in acquisitions attempting to accelerate past the ceiling that founder-led growth had created.

The transition from founder-led sales to repeatable systems — documented process, trained team, predictable pipeline — is the inflection point where most NZ-to-US expansions either professionalise or plateau.

The treatment: the founder's job in the US is not to sell. It is to build the machine that sells. The playbook must exist in writing before the first non-founder hire is made. If it only exists in the founder's head, the company cannot scale past the founder's personal capacity.

Assuming NZ product-market fit transfers to the US

Product-market fit built in New Zealand is fit against a specific competitive set, a specific buyer psychology, and a specific level of sophistication. None of these automatically transfer.

US buyers operate in a higher-noise environment. They have more alternatives, more demanding expectations, and more specific requirements for integration, compliance documentation, and demonstrated ROI. A product that won customers in NZ by being meaningfully better than one tired incumbent faces a US market where that same incumbent has five well-funded challengers.

Michael Hill International succeeded in Australia, New Zealand, and Canada — three English-speaking markets with broadly similar retail dynamics — and failed completely in the US, closing all nine US stores in 2018 after a decade of investment and a $24.85 million exit cost. The markets looked similar from the outside. They were not.

The treatment: validate product-market fit in the US specifically — with US customers, in the US competitive context — before scaling. A small cohort of reference customers who have used the product successfully in the US is the evidence required. “We think the US market needs this” is not.

Modelling US sales cycles on NZ timelines

Mid-market B2B deals in the US can take close to nine months to close. Enterprise deals can take longer. US buyers are increasingly self-directed — they prefer research-led buying journeys, make decisions by committee, and require multiple rounds of proof before engaging sales in a substantive conversation.

NZ founders model the US pipeline on NZ cycle lengths. They mistake early meetings, pilots, and positive conversations for scalable conversion. They build a twelve-month revenue plan based on a six-month sales cycle and discover that their pipeline covers six months but their burn covers twelve.

Orion Health's entire US strategy was built on the assumption that Obama-era health IT spending would close in predictable contract cycles. McCrae repeatedly cited “contract delays” as the cause of missed forecasts. The US healthcare enterprise sales cycle is not a timing problem. It is a structural feature of the market that must be modelled accurately before capital is committed.

The treatment: build the revenue model on US-native cycle length assumptions, by segment and deal size. If the pipeline and runway cannot accommodate a nine-month average close, the capital plan is wrong.

Leaving the support and service model undesigned

US enterprise and mid-market buyers expect responsive, local-hours support. The cost of providing this from New Zealand — either in staff burnout or in response latency — is almost never in the pre-entry budget.

A critical implementation issue raised by a US customer at 9am Eastern is raised at 2am Auckland time. By the time the NZ team responds, the customer has lost a day of productivity. Their internal champion loses credibility. The account becomes a churn risk. In a market where CAC is already 4–6x NZ rates, churning a customer before they have paid back their acquisition cost is not a support problem. It is a unit economics problem.

The treatment: design the support model before the first US customer goes live. Decide when a US-based Customer Success function is required, and budget for it. The Follow the Sun model must be designed as a structural feature, not assembled reactively after the first churn.

Fighting a US battle with a NZ capitalisation

NZ investors are built for NZ-scale opportunities. The typical NZ seed or Series A round is structured around capital efficiency — doing more with less. That is a virtue in a small market. It is a liability in the US, where competitors are capitalised to dominate categories and the cost of being underfunded is not slow growth but no traction at all.

Vend raised approximately US$48 million across eleven years and sold for US$350 million — a reasonable return for investors, but evidence of structural US market failure. At acquisition, the company held 0.02% of the US point-of-sale market. The acquirer, Lightspeed, had already bought a separate US company (ShopKeep) specifically to cover the US market. It bought Vend for its Asia-Pacific footprint.

Raygun, the NZ application monitoring company, estimated the ratio of US competitor capital to its own at approximately 100:1. The founder described trying to market against Sentry — which held approximately 95% US market share — as “banging your head against a wall.” Raygun held approximately 0.22%.

The treatment: be explicit about the capital required before entry. If the US business requires $5–10 million to reach traction and only $2 million is available, the choice is to raise more capital first, enter a different market, or enter in a more constrained way. Entering under-capitalised and discovering the requirement at month twelve is the worst option.

Writing messaging for NZ buyers and using it in the US

NZ marketing tends toward country-of-origin trust signals, relationship warmth, and broad applicability across industries. US buyers respond to vertical-specific expertise, quantified ROI for their specific role, and demonstrated credibility in their specific category.

“A great team from New Zealand who built a flexible platform” is not a US value proposition. “We save mid-sized community banks $2.4 million in annual compliance costs — here are five that can tell you so” is.

This is sometimes described as a cultural difference — Kiwi modesty versus American directness. It is more accurately described as a market-structure difference. US buyers in competitive categories are drowning in vendor outreach. The only message that cuts through is one that speaks their exact problem in their exact language with proof that it has worked for someone exactly like them.

The treatment: rewrite the value proposition for the US before the first sales outreach. Hire a US-native product marketer — even on a consulting basis — to strip out the generalities and replace them with vertical-specific, outcome-driven, quantified claims. Then build the US case studies that validate those claims.

Confusing demand signals with distribution readiness

Inbound interest — website traffic, social media engagement, conference conversations, inbound inquiries — is not evidence that the US market is ready to buy through a real distribution channel at scale. Distribution requires relationships, margin structures, marketing commitments, support capabilities, and pipeline systems that inbound interest does not create.

Soul Machines raised US$135 million on the strength of impressive demonstrations and marquee pilot partnerships with Mercedes-Benz, ANZ, and Air New Zealand. All three partners abandoned the technology. The demonstrations were compelling. The distribution architecture — the systems, the support model, the integration capability, the pricing that could sustain enterprise deployment — did not exist at the scale the capital raise implied. Soul Machines entered receivership in February 2026, a near-total loss of $135 million in investor capital.

The treatment: before interpreting inbound interest as market validation, map the full path from interest to profitable, retained customer. Identify the distribution channel, the economics of that channel, and the operational infrastructure required to serve customers through it. Demand that cannot be converted through a channel you can actually operate is not demand.

Arriving without the compliance certifications US buyers require

SOC 2 and HIPAA are no longer optional extras for NZ companies selling into US B2B markets. They are procurement requirements — gatekeepers that an NZ company must pass before it can be evaluated by a US mid-market or enterprise buyer's security team.

A SOC 2 Type II audit takes 6–12 months to complete and costs $30,000–$150,000 for the first year. Most NZ companies begin this process only when a US prospect asks for the report — at the final stage of a deal that could have anchored the US expansion. The deal evaporates. The audit process begins. Six months later, the next prospect asks the same question.

The treatment: begin the SOC 2 process before the first US enterprise prospect is in active evaluation. Use compliance automation platforms to maintain continuous evidence collection. Aim for at minimum a SOC 2 Type I report in hand before US sales outreach begins. If the product touches healthcare data, engage a HIPAA compliance specialist before the first customer conversation.

Ignoring legacy integration requirements as a product barrier

US buyers in established categories cannot and will not abandon their existing software stack for a new product that does not integrate with it. A healthcare product that does not integrate with Epic or Cerner will not be bought by a US health system, regardless of how superior its functionality. An HR product that does not connect to dominant payroll systems will fail at the pilot stage.

NZ companies arrive with products built for NZ market conditions — integrations with NZ systems, NZ compliance workflows, NZ operational environments. US buyers test the product, find what they like, and then ask the integration question. The answer is “no, or not yet, or we can build that.” The deal stalls. The NZ dev team diverts to integrations. The product roadmap slows.

Orion Health's US healthcare strategy ran directly into this wall. The US healthcare IT ecosystem is built on Epic and Cerner. A product that does not integrate seamlessly with these systems is not a viable product for most US health systems, regardless of its clinical merit.

The treatment: conduct a technical ecosystem audit of the US target vertical before product development is finalised for the US market. Identify the mandatory integrations — the systems that buyers cannot abandon — and build them as entry requirements, not as responses to lost deals.